XML 153 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Balance Sheet Details (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Balance Sheet Details (Details) [Line Items]    
Estimated useful lives 15 years  
Amortization expense related to intangible assets $ 36,812  
Cost of revenue 31,000  
Selling, general, and administrative expenses 6,000 $ 1,300,000
Impairment charge 14,700,000  
Impairment charge of long-lived assets $ 3,500,000
Weighted-average remaining amortization period 13 years 6 months  
Indefinite life intangible assets $ 9,300,000  
ENTADFI [Member]    
Balance Sheet Details (Details) [Line Items]    
Amortization expense related to intangible assets 37,000  
Impairment charge of long-lived assets 3,300,000  
Product Rights Intangible Asset [Member]    
Balance Sheet Details (Details) [Line Items]    
Amortization expense related to intangible assets 31,213  
Impairment charge 14,600,000  
Fixed Assets [Member]    
Balance Sheet Details (Details) [Line Items]    
Impairment charge $ 100,000  
Proteomedix [Member]    
Balance Sheet Details (Details) [Line Items]    
Estimated useful lives 15 years  
ENTADFI [Member]    
Balance Sheet Details (Details) [Line Items]    
Estimated useful lives 6 years